Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Other Accumulated Expenses (2016 - 2024)

Tenax Therapeutics' Other Accumulated Expenses history spans 5 years, with the latest figure at $39252.0 for Q4 2017.

  • On a quarterly basis, Other Accumulated Expenses fell 99.1% to $39252.0 in Q4 2017 year-over-year; TTM through Dec 2017 was $39252.0, a 99.1% decrease, with the full-year FY2017 number at $39252.0, down 99.1% from a year prior.
  • Other Accumulated Expenses hit $39252.0 in Q4 2017 for Tenax Therapeutics, down from $170711.0 in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for TENX hit a ceiling of $4.4 million in Q4 2016 and a floor of $16715.0 in Q3 2013.
  • Historically, Other Accumulated Expenses has averaged $1.6 million across 5 years, with a median of $1.3 million in 2014.
  • Biggest five-year swings in Other Accumulated Expenses: soared 2579.82% in 2015 and later crashed 99.1% in 2017.
  • Tracing TENX's Other Accumulated Expenses over 5 years: stood at $103666.0 in 2013, then soared by 724.3% to $854518.0 in 2014, then soared by 199.48% to $2.6 million in 2015, then skyrocketed by 70.43% to $4.4 million in 2016, then crashed by 99.1% to $39252.0 in 2017.
  • Business Quant data shows Other Accumulated Expenses for TENX at $39252.0 in Q4 2017, $170711.0 in Q3 2017, and $1.6 million in Q2 2017.